Advanced treatment options and hair-loss clinics have continued to emerge — and researchers are making progress on finding ...

The global alopecia treatment market is projected to grow from USD 10.8 Bn in 2025 to USD 15.8 Bn by 2032, registering a CAGR of 5.6% during the forecast period LOS ANGELES, CA, UNITED STATES ...

She highlighted her team's groundbreaking research on central centrifugal cicatricial alopecia (CCCA), explaining ... research-driven treatments. This transcript was lightly edited for clarity ...

While there is currently no cure for alopecia areata, there are a variety of treatments to try, although none are guaranteed to work. Many people experience spontaneous regrowth without treatment and ...

Female pattern baldness (androgenetic alopecia) is the most common cause of hair loss in women, but there are many other potential causes. Some effective treatment options are available.

Low-dose doxycycline showed comparable efficacy with high-dose treatment in patients with lymphocytic scarring alopecia, with a lower rate of adverse events (AEs) and related discontinuations.

Prompt diagnosis and treatment are needed to help thwart continued ... the pathogenesis of these diseases and primary cicatricial alopecia in general (Ross et al., 2005). In 2005, researchers ...

Zhang J, et al. Efficacy and safety of ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, for the treatment of adult with severe alopecia areata (AA): a randomized, double-blind ...

Patients with severe to very severe alopecia areata saw hair regrowth with bempikibart treatment within 24 weeks. Hair regrowth seemed to persist after treatment cessation to week 36. ORLANDO ...